Rethinking the INN system for therapeutic antibodies

Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes

(2016) Murli Krishna et al.   Frontiers in Immunology

Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

(2015) Ann L. White et al.   CANCER CELL

Prevention and management of obinutuzumab-associated toxicities: Australian experience

(2015) Alicia Snowden et al.   International Journal of Nursing Practice

Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A

(2015) Brian C. Tse et al.   JOURNAL OF AAPOS

Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?

(2015) Benjamin Chaigne et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

(2015) David Ternant et al.   JOURNAL OF IMMUNOLOGY

The INNs and outs of antibody nonproprietary names

(2015) Tim D. Jones et al.   mAbs

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions

(2015) Céline Monnet et al.   Frontiers in Immunology

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

(2014) K A van Schie et al.   ANNALS OF THE RHEUMATIC DISEASES

MAbImprove

(2014) André Pèlegrin et al.   mAbs

Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies

(2014) Marie Thulliez et al.   JAMA Ophthalmology

IgG Subclasses and Allotypes: From Structure to Effector Functions

(2014) Gestur Vidarsson et al.   Frontiers in Immunology

Genetic variants of IgG1 antibodies and FcγRIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells

(2014) Janardan P Pandey et al.   OncoImmunology

Immunogenicity of therapeutic proteins: Influence of aggregation

(2013) Kirsty D. Ratanji et al.   Journal of Immunotoxicology

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

(2011) Nigel M. Stapleton et al.   Nature Communications

Human immunoglobulin allotypes

(2010) Roy Jefferis et al.   mAbs

Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass

(2008) Thomas M. Dillon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY